ArticleFrontiers in immunology2019

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.

Bernadett Mácsik-Valent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.